Tyra Biosciences Inc. (TYRA)
NASDAQ: TYRA
· Real-Time Price · USD
10.85
0.12 (1.12%)
At close: Aug 18, 2025, 11:43 AM
Tyra Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -96.44M | -86.48M | -83.74M | -80.88M | -75.45M | -69.13M | -59.2M | -50.56M | -52.38M | -55.33M | -52.36M | -46.49M | -36.91M | -26.29M | -20.05M | -15.74M | -10.23M |
Depreciation & Amortization | 540K | 519K | 477K | 432K | 392K | 353K | 333K | 333K | 315K | 296K | 264K | 223K | 182K | 140K | 109K | 84K | 57.01K |
Stock-Based Compensation | 25.11M | 22.8M | 20.29M | 17.09M | 15.21M | 13.53M | 12.25M | 8.89M | 9.05M | 10.59M | 9.55M | 9.04M | 6.68M | 2.89M | 1.15M | 745K | 407.1K |
Other Working Capital | 4.15M | 318K | 6.26M | 4.73M | -1K | 6.36M | -2.18M | -2.58M | -8.99M | -8.2M | -7.03M | -6.89M | -1.58M | -1.97M | -814K | -135K | -76.06K |
Other Non-Cash Items | -1.91M | 2.09M | 6.42M | 9.07M | 6.28M | 3.15M | -5.84M | -5.84M | -3.02M | -3.02M | 2.35M | 2.35M | -86K | 130K | 615K | 612.14K | 220.3K |
Deferred Income Tax | n/a | n/a | -4.39M | -4.39M | -4.39M | -4.39M | 5.85M | 5.85M | 3.02M | 3.02M | -2.34M | -2.34M | 483K | 483K | n/a | n/a | n/a |
Change in Working Capital | 4.15M | 318K | 6.26M | 4.73M | -1K | 6.36M | -1.97M | -2.33M | -8.19M | -5.85M | -4.79M | -3.47M | 2.05M | -481K | 1.54M | 1.13M | 443.94K |
Operating Cash Flow | -73.2M | -69.77M | -63.72M | -62.96M | -62.32M | -50.14M | -48.59M | -43.65M | -51.21M | -50.28M | -47.33M | -40.7M | -27.99M | -23.75M | -17.25M | -13.78M | -9.32M |
Capital Expenditures | -542K | -664K | -1.26M | -1.29M | -865K | -770K | -188K | -153K | -361K | -559K | -643K | -851K | -840K | -661K | -623K | -475K | -235.08K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16K | 16K | 16K | 16K | n/a | n/a |
Purchase of Investments | -258.7M | -263.62M | -369.42M | -333.03M | -155.63M | -143.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 174.79M | 165.88M | 120.89M | 62.88M | 30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -144.52K | -126.31K | -270.15K | -270.15K | -125.63K | -143.84K | n/a | n/a | n/a | n/a | n/a | 16K | 16K | 16K | 16K | n/a | n/a |
Investing Cash Flow | -84.45M | -98.4M | -249.8M | -271.44M | -126.49M | -144.6M | -188K | -153K | -361K | -559K | -643K | -835K | -824K | -645K | -607K | -475K | -235.08K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | -9K | -13K | -19K | -17K |
Common Stock Repurchased | 169K | n/a | n/a | -420K | -169K | n/a | n/a | n/a | n/a | n/a | n/a | -23K | -23K | -23K | -23K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.01M | 2.31M | 1.92M | 1.65M | 1.65M | 1.54M | 1.22M | 749K | 379K | 3K | n/a | 183.46M | 182.73M | 312.88M | 312.88M | 129.43M | 130.28M |
Financial Cash Flow | 4.01M | 202.14M | 201.75M | 201.48M | 201.48M | 1.54M | 1.21M | 746.37K | 376.39K | 632.00 | -1.51M | 181.93M | 181.2M | 311.35M | 312.85M | 129.41M | 130.14M |
Net Cash Flow | -153.65M | 33.96M | -111.76M | -132.92M | 12.66M | -193.21M | -47.56M | -42.69M | -50.8M | -50.21M | -48.85M | 140.66M | 152.62M | 286.96M | 295M | 115.15M | 120.58M |
Free Cash Flow | -73.75M | -70.44M | -64.98M | -64.25M | -63.19M | -50.91M | -48.77M | -43.81M | -51.57M | -50.84M | -47.98M | -41.55M | -28.83M | -24.41M | -17.87M | -14.26M | -9.56M |